| 000 | 01708 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515160128.0 | ||
| 264 | 0 | _c20090417 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1528-4336 | ||
| 024 | 7 |
_a10.1310/hct0906-445 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarcellin, Fabienne | |
| 245 | 0 | 0 |
_aDepressive symptoms and exposure to efavirenz in West African HIV-infected adults. _h[electronic resource] |
| 260 |
_bHIV clinical trials _c |
||
| 300 |
_a445-7 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAfrica, Western _xepidemiology |
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzoxazines _xadministration & dosage |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 |
_aDepression _xepidemiology |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterviews as Topic |
| 650 | 0 | 4 |
_aLamivudine _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aZidovudine _xadministration & dosage |
| 700 | 1 | _aMoh, Raoul | |
| 700 | 1 | _aCarrieri, Maria Patrizia | |
| 700 | 1 | _aDanel, Christine | |
| 700 | 1 | _aProtopopescu, Camelia | |
| 700 | 1 | _aGabillard, Delphine | |
| 700 | 1 | _aSpire, Bruno | |
| 700 | 1 | _aAnglaret, Xavier | |
| 773 | 0 |
_tHIV clinical trials _gvol. 9 _gno. 6 _gp. 445-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1310/hct0906-445 _zAvailable from publisher's website |
| 999 |
_c18647991 _d18647991 |
||